First Anticancer Drug via On-Body Injector

Company: Sanofi (EURONEXT: SAN; Nasdaq: SNY) Event Type: FDA approval — subcutaneous formulation, ahead of the July 23 PDUFA Modality: Anti-CD38 monoclonal antibody, subcutaneous — delivered via CirCLIQ on-body injector (Enable Injections enFuse platform) and manual SC Target: CD38 Indication: Multiple myeloma — all currently…